Novartis Korea Chief Lauds Government Investment In Local Drug Industry
This article was originally published in PharmAsia News
Executive Summary
The head of Novartis Korea says South Korea's planned investment of $1.8 billion in building a local biopharmaceutical industry makes it a key emerging market for the global industry